Automate Your Wheel Strategy on PGNY
With Tiblio's Option Bot, you can configure your own wheel strategy including PGNY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PGNY
- Rev/Share 14.4808
- Book/Share 6.0049
- PB 4.2082
- Debt/Equity 0.0495
- CurrentRatio 2.6966
- ROIC 0.0841
- MktCap 2178568497.0
- FreeCF/Share 2.2176
- PFCF 11.4543
- PE 40.7973
- Debt/Assets 0.0335
- DivYield 0
- ROE 0.1155
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 3
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PGNY | KeyBanc Capital Markets | Sector Weight | Overweight | -- | $30 | Nov. 12, 2025 |
| Upgrade | PGNY | Leerink Partners | Market Perform | Outperform | -- | $28 | July 8, 2025 |
| Downgrade | PGNY | JMP Securities | Mkt Outperform | Market Perform | -- | -- | Sept. 19, 2024 |
News
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m.
Read More
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Read More
About Progyny, Inc. (PGNY)
- IPO Date 2019-10-25
- Website https://www.progyny.com
- Industry Medical - Healthcare Information Services
- CEO Peter Anevski
- Employees 675